Ajanta Pharma: Revised SEBI Takeover Code Disclosures Filed

Ajanta Pharma Limited has filed revised disclosures under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, concerning encumbrances on equity shares. The revision clarifies the particulars of the entities in whose favor shares have been encumbered, specifically naming both the lender and the trustee, addressing a discrepancy noted by the BSE. The original disclosures only mentioned the trustee's name. This update ensures compliance with regulatory requirements for specifying beneficiaries of encumbrances, such as pledges for non-convertible debentures.